ADDISON, Texas, March 22, 2012 /PRNewswire/ -- ULURU
Inc. (NYSE AMEX: ULU) today announced that it has scheduled a
conference call to discuss the fourth quarter and year ended
December 31, 2011 financial results
and to provide a general business update on Monday, April 2, 2012 at 9:00 a.m. Eastern Time.
To participate in the conference call please dial (800)
357-0498, for international callers dial (850) 429-1388 (access
code 23854#) five to ten minutes prior to the initiation of the
teleconference. If you are unable to listen to the live
broadcast, a replay of the call will be available starting on
April 2, 2012 two hours following the
end of the call until April 9, 2012
at 11:59 p.m. Eastern Time. For
the U.S. replay, please dial (866) 415-9493 and international
callers please dial (585) 419-6446 (access code 23854#). You
may also access the replay of the call two hours following the end
of the call until April 9, 2012 at
11:59 p.m. Eastern Time via the web
by logging onto
http://app.replayrecorder.com/multipoint/.
About ULURU Inc.:
ULURU Inc. is a specialty pharmaceutical company focused on the
development of a portfolio of wound management and oral care
products to provide patients and consumers with improved clinical
outcomes through controlled delivery utilizing its innovative
Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery
system. For more information about ULURU Inc., please visit
www.uluruinc.com. For more information about Altrazeal®,
please visit www.Altrazeal.com.
This press release contains certain statements that are
forward-looking within the meaning of Section 27a of the Securities
Act of 1933, as amended. These statements are subject to numerous
risks and uncertainties, including but not limited to the risk
factors detailed in the Company's Annual Report on Form 10-K for
the year ended December 31, 2010 and
other reports filed by us with the Securities and Exchange
Commission.
Contact: Company
Kerry P. Gray
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145
SOURCE ULURU Inc.